Health & Life Sciences

News

Filter:

19 results for “Pharmacy”

04/06/21 – Media Mention Brenda Maloney Shafer, Richard Davis and David Blank’s Article Showcased in Pratt’s Government Contracting Law Report Many drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs guidance on contract pharmacy encounters are causing significant disruption in operations and generating a loss of revenue for all types of 340B covered entities.... More Pratt’s Government Contracting Law Report

03/18/21 – Media Mention Simone Colgan Dunlap Provides Insight in “The Legal Landscape for Patient Support Services” Simone Colgan Dunlap spoke to Pharmaceutical Commerce and discussed the significance for pharmacy benefit managers (PBMs) of the Rutledge v. Pharmaceutical Care Management Associate (PCMA) decision using the federal Employee Retirement Income Security Act of 1974 (ERISA) to strike down... More Pharmaceutical Commerce

01/11/21 – Media Mention Katea Ravega Provides Perspective in “Supreme Court Ruling May Open the Door for More Widespread Legislation Limiting Power of PBMs” Katea Ravega spoke with Pharmacy Times in a recent interview regarding the U.S. Supreme Court ruling in Rutledge v. Pharmaceutical Care Management Association (PCMA) and what this decision could mean for the future of states' legislation around pharmacy benefit managers... More Pharmacy Times

03/09/19 – Media Mention Podcast: VillageMD Working Smarter – The Opioid Epidemic’s Impact on Your Practice More VillageMD Working Smarter

08/10/17 DIR Fees and Value-Based Contracting in Focus for Specialty Pharmacy With an aging U.S. population and advances in the treatment of increasingly complex and chronic conditions, the specialty pharmacy industry is booming. Sales are expected to account for 50 percent of pharmacy revenues by 2020, according to some estimates. With this... More

08/07/17 Compounding Confusion: Uncertainty Swirls in Compound Pharmacy Regulation Five years after the New England Compounding Center tragedy led the FDA to step in as a primary regulator of compounding pharmacies, uncertainties and anxieties abound. That was the thread running through a discussion led by Quarles & Brady partners Theodore... More

08/04/17 Opioid Crisis Prompts Lawsuits and Tighter Regulation of Pharmacy Industry With the opioid crisis sweeping the country, cities, counties and states are filing suits against the various players in the pharmacy industry – including manufacturers, wholesalers and retailers. About two dozen suits have been filed since 2016, with more likely on... More

08/02/17 Health Care Drama, Cyber Risk Take Center Stage It’s not often that the hottest topic in pharmacy law also dominates front pages and newscasts across the country. But that was precisely the case when pharmacy attorneys and executives gathered at Quarles & Brady’s 3rd Annual Pharmacy Law Symposium... More

08/02/17 Mounting Risks Abound in Data Privacy, Security Ask a room full of pharmacy attorneys and executives to raise their hands if they’re concerned about data privacy and security, and you’ll likely get a nearly unanimous response: they are. And that’s exactly what happened at Quarles & Brady’s... More

07/31/17 No Stone Unturned: Due Diligence in Pharmacy Transactions Due diligence matters in any business transaction, but the thicket of regulations and licensure requirements that govern the pharmacy industry make thorough diligence the most critical part of any deal in that business. That was the key message delivered by Quarles... More

10/21/16 – Media Mention Roger N. Morris featured in “AZ Business Leaders” Below is an excerpt: Arizona Pharmacy Association Pharmacy Hall of Fame inductee Morris represents pharmacy providers nationwide. Morris is a member of Quarles’ governing Executive Committee, national chair of Quarles’ Health and Life Sciences Industry Group and former national chair of... More AZ Business Leaders

05/10/16 – Media Mention Edward D. Rickert quoted in article “Connected: Telepharmacy Unites the Team” Below is an excerpt: One of the primary drivers of telehealth and telepharmacy is the fact that people like convenience and they are used to getting things quickly and easily, said Rickert, citing the example of automated banking. "Society as a whole... More Drug Topics

04/15/16 – Media Mention Susan B. Trujillo quoted in article “3 Takeaways From FDA’s Drug Compounding Guidances” Below is an excerpt: Quarles & Brady LLP partner Susan B. Trujillo predicted that the FDA's position will draw fire from 503B outsourcing facilities that invested heavily in manufacturing upgrades but expected to maintain the capacity to operate more flexibly in... More Law360

03/06/16 – Media Mention Roger N. Morris quoted in article “5 Court Cases Involving Pharmacists” Below is an excerpt: Should a pharmacist-in-charge be held liable for a technician’s theft? Can a pharmacist who is afraid of needles be fired for not providing immunizations? These were some of the legal questions posed during a session on pharmacy case... More Pharmacy Times

08/21/15 – Media Mention Roger Morris featured in article “Health Care Heroes” Below is an excerpt: Roger Morris was a pharmacist for several years before he earned his law degree in 1989. He has been with Quarles & Brady LLP since then, working with pharmacy and health care providers as well as state... More The Business Journal of Phoenix

01/01/14 – Media Mention Sarah E. Coyne quoted in article “Life Sciences Regulation And Legislation To Watch In 2014: A New World for Off-Label Marketing” Following is an excerpt: Recent directives by the U.S. Food and Drug Administration, federal courts and Congress will drive some big regulatory shifts in the life sciences field in 2014, with attorneys watching especially the implementation of the newly passed Drug... More Law360

01/01/14 – Media Mention Roger N. Morris featured in article “Life Sciences Regulation And Legislation To Watch In 2014: A New World for Off-Label Marketing” Following is an excerpt: Recent directives by the U.S. Food and Drug Administration, federal courts and Congress will drive some big regulatory shifts in the life sciences field in 2014, with attorneys watching especially the implementation of the newly passed Drug... More Law360

06/24/13 – Media Mention Roger N. Morris quoted in article “Lawyers React To High Court’s Generic-Drug Liability Ruling” Following is an excerpt: The U.S. Supreme Court ruled 5-4 Monday that users of generic drugs cannot bring state-law design defect claims against generics makers because the manufacturers cannot change a drug's design under federal law. Here, attorneys tell Law360 why... More Law360

07/01/12 – Media Mention Roger N. Morris quoted in article “With more cha-ching, will PDUFA V satisfy on the ba-bling?” Scrip Intelligence